A double-blind, randomized, placebo-controlled, two-centre, phase IIa pharmacodynamic cross-over study to assess the effect of AZD2516 on the total number of reflux episodes in healthy male volunteers.
The purpose of this study is to investigate the pharmacodynamic effect of AZD2516 in healthy male subjects.